전체메뉴

Journal of Pharmacopuncture

Article Search

JoP

For Authors

Recently updated April 09, 2020

Introduction

The Journal of Acupuncture and Meridian Studies (JAMS) is a bimonthly, peer-reviewed and open access journal. JAMS aims to disseminate evidence-based scientific findings on the acupuncture and meridian to researchers and clinicians in the field of complementary and alternative medicine, and in the other health-related fields. The journal will publish high-quality studies on the anatomy and physiology of acupoints and meridians, and mechanism of action of acupuncture treatment, and clinical application of acupuncture. The journal welcomes the original articles on the acupuncture and related approaches (acupressure, electroacupuncture, laser acupuncture, moxibustion and cupping, etc.), pharmacopuncture and veterinary acupuncture.
The journal is indexed in MedLine/PubMed/Index Medicus, Emerging Sources Citation Index (ESCI), SCOPUS, ScienceDirect, EMBASE, CINAHL Plus, Google Scholar, DOAJ, Korea Citation Index (KCI), SHERPA/RoMEO, EZB, and Research Bible. Its abbreviated title is J Acupunct Meridian Stud. This journal was supported by the Korean Federation of Science and Technology Societies Grant funded by the Korean Government (Ministry of Education).
JAMS is an open access journal: JAMS is supported by Medical Association of Pharmacopuncture Institute for Article Publishing Charge (APC). There is no charge to publish in this journal. Therefore, all articles will be immediately and permanently free for everyone to read and download. All articles published by Journal of Acupuncture and Meridian Studies are made freely and permanently accessible online immediately upon publication, without registration barriers. The Editorial Board requires authors to be in compliance with the Uniform Requirements for Manuscripts Submitted to Biomedical Journals (URMs); current URMs are available at http://www.icmje.org.
It also adheres completely to the Principles of Transparency and Best Practice in Scholarly Publishing (joint statement by COPE, DOAJ, WAME, and OASPA; http://doaj.org/bestpractice) if otherwise not described below.

1. Manuscript Submission

Authors are requested to submit their manuscript through the Editorial Manager, available at https://www.editorialmanager.com/JAAMS. For any further inquiries relating to manuscript submission, please contact the Editorial Office (journalams@gmail.com).

Important information • Articles submitted by e-mail should be in Microsoft Word document format (*.doc or *.docx) and prepared in the simplest form possible. We will add in the correct font, font size, margins, and so on according to the journal's style.
• You may use automatic page numbering, but do NOT use other kinds of automatic formatting such as footnotes, endnotes, headers, and footers.
• Put text, references, tables, figures, and legends in one file, with each table and figure on a new page.
• Figures that are line drawing or photographs must be submitted separately in high-resolution EPS, TIFF, JPEG, or PPT format. Please ensure that files are supplied at the correct resolution of a minimum of 300 dpi. The files are to be named according to the figure number and format, e.g. Fig1.tif.

Please ensure that the following submission documents are also included, where applicable:
(1) A cover letter must include your name, ORCID ID (Open Researcher and Contributor ID), address, telephone and fax numbers, e-mail address, and a list of up to five suggested reviewers with their contact information, and state that all authors have contributed to the paper and have never submitted the manuscript, in whole or in part, to other journals.
(2) A conflict of interest disclosure statement (see the relevant section below).
(3) Articles covering the use of human samples in research and human experiments must be approved by the relevant review committee (see the relevant section below).
(4) Articles covering the use of animals in experiments must be approved by the relevant authorities.
(5) Articles where human subjects can be identified in descriptions, photographs or pedigrees must be accompanied by a signed statement of informed consent to publish (in print and online) the descriptions, photographs, and pedigrees from each subject who can be identified (see the relevant section below).
(6) Where material has been reproduced from other copyrighted sources, the letter(s) of permission from the copyright holder(s) to use the copyrighted sources must be supplied.

2. Before You Begin

2.1. Ethics in publishing All of the manuscripts should be prepared based on strict observation of research and publication ethics guidelines recommended by the Council of Science Editors (http://www.councilscienceeditors.org). For information on Ethics in publishing and Ethical guidelines for journal publication see https://www.elsevier.com/publishingethics and https://www.elsevier.com/journal-authors/ethics

2.2. Ethical Approval of Studies All studies involving human subjects or human data must be reviewed and approved by a responsible Institutional Review Board (IRB). Animal experiments also should be reviewed by an appropriate committee (IACUC) for the care and use of animals. Also, studies with pathogens requiring a high degree of biosafety should pass a review of a relevant committee (IBC). The approval should be described in the Methods section. For those investigators who do not have formal ethics review committees, the principles outlined in the Declaration of Helsinki should be followed (World Medical Association. Declaration of Helsinki: ethical principles for medical research involving human subjects. Available at: https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects/). The editor of JAMS may request submission of copies of informed consent from human subjects in clinical studies or IRB approval documents. The JAMS will follow the guidelines by the Committee on Publication Ethics (COPE, http://publicationethics.org/) for settlement of any misconduct.

2.3. Identification of Patients in Descriptions, Photographs, and Pedigrees A signed statement of informed consent to publish (in print and online) patient descriptions, photographs and pedigrees should be obtained from all subjects (parents or legal guardians for minors) who can be identified (including by the subjects themselves) in such written descriptions, photographs or pedigrees. Such persons should be shown in the manuscript before its submission. Omitting data or making data less specific to de-identify patients is acceptable but changing any such data is not acceptable.

2.4. Conflict of interest The corresponding author of an article is asked to inform the Editor of the authors' potential conflicts of interest that may possibly influence the research or interpretation of data. A potential conflict of interest should be disclosed in a ‘Disclosure’ statement, and in the cover letter even when the authors are confident that their judgments have not been influenced during the study or in preparing the manuscript. Such conflicts may include financial support or private connections to pharmaceutical companies, political pressure from interest groups, or academic problems.
The submitted Disclosure format shall follow that of the International Committee of Medical Journal Editors (ICMJE) Uniform Disclosure Form for Potential Conflicts of Interest (http://www.icmje.org/about-icmje/faqs/conflict-of-interest-disclosure-forms/). The Editor will decide whether the information on the conflict should be included in the published paper. In particular, all sources of funding for a study should be explicitly stated. The JAMS asks referees to let the Editor know of any conflict of interest before undertaking a review of a given manuscript.
All authors are requested to disclose any actual or potential conflict of interest including any financial, personal or other relationships with other people or organizations within three years of beginning the submitted work that could inappropriately influence, or be perceived to influence, their work. See also https://www.elsevier.com/conflictsofinterest. Further information and an example of a Conflict of Interest form can be found at: http://service.elsevier.com/app/answers/detail/a_id/286/supporthub/publishing.

2.5. Submission declaration Submission of an article implies that the work described has not been published previously (except in the form of an abstract or as part of a published lecture or academic thesis or as an electronic preprint, see https://www.elsevier.com/sharingpolicy), that it is not under consideration for publication elsewhere, that its publication is approved by all authors and tacitly or explicitly by the responsible authorities where the work was carried out, and that, if accepted, it will not be published elsewhere including electronically in the same form, in English or in any other language, without the written consent of the copyright holder.

Examples of author contributions
Conceptualization: name; Data curation: name; Formal analysis: name; Funding acquisition: name; Investigation: name; Methodology: name; Project administration: name; Resources: name; Software: name; Supervision: name; Validation: name; Visualization: name; Writing - original draft: name; Writing - review & editing: name.

The Editor assumes that all author(s) listed in a manuscript have agreed with the following JAMS policies on manuscript submission: 1) The manuscript submitted to the JAMS must be previously unpublished and not be under consideration for publication elsewhere; 2) the identities of referees will not be revealed under any circumstances; and 3) if an author(s) should be added or deleted after submission of manuscript, it is the responsibility of the corresponding author to ensure that all the authors involved are aware of and agree to the change in authorship. The JAMS has no responsibility for such changes.

2.7. Changes to authorship Authors are expected to consider carefully the list and order of authors before submitting their manuscript and provide the definitive list of authors at the time of the original submission. Any addition, deletion or rearrangement of author names in the authorship list should be made only before the manuscript has been accepted and only if approved by the journal Editor. To request such a change, the Editor must receive the following from the corresponding author: (a) the reason for the change in author list and (b) written confirmation (e-mail, letter) from all authors that they agree with the addition, removal or rearrangement. In the case of addition or removal of authors, this includes confirmation from the author being added or removed. Only in exceptional circumstances will the Editor consider the addition, deletion or rearrangement of authors after the manuscript has been accepted. While the Editor considers the request, the publication of the manuscript will be suspended. If the manuscript has already been published in an online issue, any requests approved by the Editor will result in a corrigendum.

2.8. Copyright All published papers become the permanent property of the Medical Association of Pharmacopuncture Institute. Copyrights of all published materials are owned by the Medical Association of Pharmacopuncture Institute. Permission must be obtained from the Medical Association of Pharmacopuncture Institute for any commercial use of materials. Every author should sign the copyright transfer agreement forms.

2.9. Open access Every peer-reviewed research article appearing in this journal will be published open access. This means that the article is universally and freely accessible via the internet in perpetuity, in an easily readable format immediately after publication. The author does not have any publication charges for open access. The Medical Association of Pharmacopuncture Institute will pay to make the article open access. A CC user license manages the reuse of the article (see https://www.elsevier.com/openaccesslicenses). All articles will be published under the following license: Creative Commons Attribution-NonCommercial-NoDerivs (CC BY-NC-ND): For non-commercial purposes, lets others distribute and copy the article, and to include in a collective work (such as an anthology), as long as they credit the author(s) and provided they do not alter or modify the article.

2.10. Role of the funding source You are requested to identify who provided financial support for the conduct of the research and/or preparation of the article and to briefly describe the role of the sponsor(s), if any, in study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the article for publication. If the funding source(s) had no such involvement, then this should be stated.

2.11. Submission Our online submission system guides you stepwise through the process of entering your article details and uploading your files. The system converts your article files to a single PDF file used in the peer-review process. Editable files (Microsoft Word file; *.doc or *.docx) are required to typeset your article for final publication. All correspondence, including notification of the Editor's decision and requests for revision, is sent by e-mail.

3. Categories of Articles

3.1. Review Articles Review articles describe new developments of the significance in the field of acupuncture and meridian studies and highlight unresolved questions and future directions. Most reviews are solicited by the editors, but unsolicited submissions may also be considered for publication. Review articles must not include unpublished material (unpublished/original data, submitted manuscripts, or personal communications). Review articles should have an Abstract and keywords, Introduction, brief main headings (subsections relevant for the subject), Discussion, and Conclusions.
Maximum length: One paragraph with maximum of 250 words for the abstract; maximum of 6,500 words from Introduction to Conclusion; maximum of 100 references, 10 tables and figures.

3.2. Research Articles Research articles are expected to present major advances and important new research results related to acupuncture and meridian studies.
Section headings should be written in the following format: Abstract and keywords; Introduction; Materials and Methods; Results; Discussion; Conclusions (if any); Acknowledgements; References; and Tables and Figures.
The abstract should be structured with maximum of 250 words as follows: Background, Objectives, Methods, Results, and Conclusions.
Introduction should provide concise yet sufficient background information about the study to provide the readers with a better understanding of the study, avoiding a detailed literature survey or a summary of the results.
Materials and Methods should contain detailed procedures of the experiment including investigation period, methods of subject selection, and information on subjects such as age, gender, and other significant features, in order to enable the experiment to be repeated. The procedure which has been already published or standardized shall be described only briefly using literature citations. Clinical trials or experiments involving laboratory animals or pathogens must elaborate animal care and use and experimental protocols, in addition to mentioning the approval from the relevant committees. The sources of special equipment and chemicals must be stated with the name and location of the manufacturer (city and country). All statistical procedures used in the study and criteria for determining significance levels must be described. The Theory / Calculation should extend, not repeat, the background to the article already dealt with in the Introduction and provide the foundation for further work. In contrast, a Calculation section represents a practical development from a theoretical basis.
Results should be presented in a logical sequence. Only the most important observation should be emphasized or summarized, where the main or the most important findings should be mentioned first. Table and figures must be numbered in the order they are cited in the text, kept to a minimum, and should not be repeated. Supplementary materials and other details can be separately sited in an appendix. State the statistical method used to analyze the results (statistical significance of differences) with the probability values given in parentheses.
Discussion should contain interpretation and explanation of the results and important aspects of the study, followed by the conclusion drawn from them. The information already mentioned in Introduction or Results sections should not be repeated and the main conclusions of the study may be presented in the discussion.
Conclusions must be linked with the purpose of the study stated in the abstract, clearly supported by the data produced in the study. New hypotheses may be stated when warranted but must be clearly labeled.
Maximum length: Up to 4,000 words excluding Abstract, References, and Figure/Table Legends.
Structured abstract with maximum of 250 words; Up to 4,000 words excluding Abstract, References, and Figure/Table Legends; maximum of 50 references, 10 tables and figures.

3.3. Perspective Articles These articles present novel views and insights on topics of current interest in basic and clinical acupuncture and meridian research. Examples of potential manuscripts for publication as a perspective are a discussion of controversial issues, a summary update of a series of presentations at a scientific meeting, clinical perspectives on the diagnosis or treatment of a particular disease, or other similar topics in acupuncture and meridian research.
Maximum length: Up to 1,500 words excluding Abstract, References, and Figure/Table Legends. One paragraph with maximum of 100 words for the abstract; maximum of 10 references, 2 tables and figures.

3.4. Brief Reports These are short peer-reviewed papers presenting novel results in basic acupuncture and meridian studies. Section headings should be: Abstract and keywords, Introduction, Materials and Methods, Results, Discussion, and References.
Maximum length: Up to 2,000 words excluding Abstract, References, and Figure/Table Legends. One paragraph with maximum of 250 words for the abstract; maximum of 20 references, 4 tables and figures.

3.5. Case Reports These are short peer-reviewed papers presenting novel findings in clinical studies. Case Reports deal with unreported or unusual cases in drug therapy or in the presentation of a disease. The authors should state the findings, clinical courses, the prognoses of the case, and present a review of other related and previously reported cases. The CARE guidelines checklist (https://www.care-statement.org/checklist) should be submitted with the manuscript. Case Reports should make a contribution to acupuncture and meridian knowledge and must have educational value or highlight the need for a change in clinical practice or diagnostic/prognostic approaches. Section headings should be: Abstract and keywords, Introduction, Case presentation, Discussion, Acknowledgments, References, Figures or Tables. You may find out the sample for a regular case report at www.jams-kpi.com.
Maximum length: Up to 2,000 words excluding Abstract, References, and Figure/Table Legends. One paragraph with maximum of 250 words for the abstract; maximum of 20 references, 6 tables and figures.

3.6. Protocol & Technical Note These are short peer-reviewed papers presenting novel protocols in basic acupuncture and meridian studies. They also present new techniques for instruments and acupuncture. Receipt of technical notes will not be acknowledged nor are authors generally consulted before publication. Section headings should be: Abstract and keywords, Introduction, Materials, Procedure, Timing, Troubleshooting, and Anticipated Result.
Maximum length: Up to 2,000 words excluding Abstract, References, and Figure/Table Legends. One paragraph with maximum of 250 words for the abstract; maximum of 20 references, 6 tables and figures.

3.7. Impact Shot The purpose of Impact Shot is to provide researchers and potential authors the opportunity to present the essence of their research in a 'One-Figure' (with several panels) format to have a 'Deep Impact' on the research community and general public. The figure must be clear and concise in the message. The motto of the Impact Shot is "A figure speaks louder than words".

PREPARING YOUR SUBMISSION TO IMPACT SHOT
• Please include a title for your submission. The title should contain no more than eight words.
• The legend should contain no more than 150 words.
• The figure should be a completed one that does not need to be revised in the editorial procedure. For figures, it is permissible to send low-resolution images for peer review, although we may ask for high-resolution files at a later stage. Please submit a high-resolution still image.

The legend of the image should succinctly present relevant research information. All labeled structures in the image should be described and explained in the legend. Please, refer to the example of the Impact Shot at http://www.jams-kpi.com/article/S2005-2901(14)00060-0/pdf. An abstract is not required.
Maximum length: Up to 150 words. No abstract; maximum of 5 references, 1 figure.

3.8. Guidelines and Recommendations These articles are to introduce consensual or official statements of various organizations of basic and clinical acupuncture and meridian research. The article should be presented in accordance with a structured and transparent process, such as that for the GRADE guidelines (https://www.gradeworkinggroup.org). The numbers of words, references, figures, and tables in the main body are not limited. The abstract should be an unstructured single paragraph of fewer than 150 words. These articles are normally solicited by the editors, but an unsolicited submission will be considered. The manuscript will undergo the same peer-review process as that for research articles.
Maximum length: One paragraph with maximum of 150 words for the abstract.

3.9. Book Reviews These evaluate books on acupuncture and meridian studies and related subjects. Receipt of book reviews will not be acknowledged nor are authors generally consulted before publication.
Maximum length: Up to 400 words. No abstract.

3.10. Letters to the Editor These are letters about readers' opinions or issues of concern on previously published articles in the journal. Receipt of letters will not be acknowledged nor are authors generally consulted before publication. The text should be limited to 500 words (including spaces) and accepted letters are subject to editing for clarity and space. An abstract is not required.
Maximum length: Up to 500 words. No abstract; maximum of 10 references, 2 tables and figures.

3.11. Editorials Editorials are invited articles or comments and should be commentaries on articles published recently in the journal. Editorial topics could include active areas of research, fresh insights, and debates in all fields of journal publication. Editorials should not exceed 1,000 words, excluding references, tables, and figures. References should not exceed 10. A maximum of 3 figures including tables is allowed. An abstract is not required.
Maximum length: Up to 1000 words. No abstract; maximum of 10 references, 3 tables and figures.

3.12. Corrections Corrections including erratum and corrigendum provide a means of correcting errors in a published article. Erratum and corrigendum should be sent directly to the Editor-in-Chief and are treated in the same manner as a formally published paper. An erratum is to notify the errors accused during the production of the journal article, including errors of omission such as failure to make factual proof corrections requested by authors within the deadline provided by the journal and within journal policy. A corrigendum is a notification of a significant error made by the authors of the article. All corrigenda are normally approved by the editors of the journal.

Table 1 shows the recommended maximums of manuscripts according to publication type: However, these requirements are negotiable with the editor.

Table 1 Recommended maximums for articles submitted to the Journal of Acupuncture and Meridian Studies

Type of article Abstract (Word) Text (Word)a) References Tables & Figures
Review article 250 6,500 100 10
Research article 250 (structured) 4,000 50 10
Perspective article 100 1,500 10 2
Brief report 250 2,000 20 4
Case report 250 2,000 20 6
Protocol & Technical note 250 2,000 20 6
Impact shot No 150 5 1
Guidelines and recommendations 150 not specified not specified not specified
Book review No 400 not specified not specified
Letter to the editor No 500 10 2
Editorial No 1,000 10 3

a) Maximum number of words is exclusive of the tables, figures, and references.

4. Reporting Guidelines

The JAMS recommends that authors make use of reporting guidelines that are appropriate to the type of the manuscript in preparation, and to indicate the reporting guideline(s) used in the Methods section of the submitted manuscript. Reporting guidelines are available through the EQUATOR(Enhancing the Quality and Transparency of Health Research) Network (http://www.equator-network.org) or other websites. Compliance with the appropriate reporting guidelines will be enforced through editorial and peer review. Representative reporting guidelines include:
• CONSORT (Consolidated Standards of Reporting Trials)-for clinical trials (http://www.consort-statement.org/)
• STRICTA (STandards for Reporting Interventions in Clinical Trials of Acupuncture)-for clinical acupuncture trials (https://www.stricta.info/)
• STARD (Standards for the Reporting of Diagnostic Accuracy Studies)-for diagnostic test evaluation
• STROBE (Strengthening the Reporting of Observational Studies in Epidemiology)-for cross-sectional, case-control, and cohort studies
• PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses)-for systematic reviews and meta-analyses (http://www.prisma-statement.org/)
• ARRIVE (Animal Research: Reporting of In Vivo Experiments)-for all studies involving laboratory animals (https://www.nc3rs.org.uk/arrive-guidelines)
• SPQR (Standards for Reporting Qualitative Research)-for all studies involving qualitative research
• CARE (Case Report Guidelines)-for clinical case reports (http://www.care-statement.org)
• GRADE(Grading of Recommendations Assessment, Development, and Evaluation)-for using to assess evidence or develop recommendations (https://www.gradeworkinggroup.org)

5. Preparation

5.1. Use of word processing software It is important that the file be saved in the native format of the word processor used. The text should be in single-column format. Keep the layout of the text as simple as possible. Most formatting codes will be removed and replaced on processing the article. In particular, do not use the word processor's options to justify text or to hyphenate words. However, do use boldface, italics, subscripts, superscripts, etc. When preparing tables, if you are using a table grid, use only one grid for each individual table and not a grid for each row. If no grid is used, use tabs, not spaces, to align columns. The electronic text should be prepared in a way very similar to that of conventional manuscripts (see also the Guide to Publishing with Elsevier: https://www.elsevier.com/guidepublication). Note that source files of figures, tables, and text graphics will be required whether or not you embed your figures in the text. See also the section on Electronic artwork. To avoid unnecessary errors you are strongly advised to use the 'spell-check' and 'grammar-check' functions of your word processor.

5.2. Manuscript Preparation Manuscripts should be typed double-spaced throughout. Each section of the manuscript should begin on a new page. Pages should be numbered consecutively and organized as follows

5.2.1. Cover Letter
The corresponding author should highlight the key points and originality of the article in few sentences and provide written assurance that neither the submitted materials nor portions thereof have been published previously or are under consideration for publication elsewhere. When more than one related manuscript has been published or is under consideration for publication by this or other journals, authors are required to declare this in their letter and to enclose copies of those publications for editorial perusal.
Authors may recommend experts in the field of the manuscript’s content as potential reviewers. The suggested reviewers may not be working at the same institution and, preferably, not in the same country as the corresponding author(s).

5.2.2. Title Page
The title page should contain the following information:
• category of paper
• article title*
• names (spelled out in full) of all authors** with their ORCID IDs, and the institutions with which they are affiliated
• short running title not exceeding 50 characters
• corresponding author details: name, academic degree, e-mail address, mailing address (institutional affiliation, city, postal code, and country), telephone and fax numbers
• Contribution of each author and funding sources should be included as footnotes on the title page.
• declaration of any source of financial support
* The article title should not exceed two lines in print. This equates to 100 characters (including spaces) for articles. The article title does not normally include numbers, acronyms, abbreviations or punctuation. It should include sufficient detail for indexing purposes but be general enough for readers outside the field to appreciate what the paper is about.
** The name of each author should be written with the family name last, e.g. Charles Darwin. Authorship is restricted only to direct participants who have contributed significantly to the work.

5.2.3. Abstracts and keywords
The abstract should effectively present the contents of the manuscript in less than 250 words. In principle, acronyms and informal abbreviations should be avoided, but, if needed, they should be kept to an absolute minimum with proper identifications. 4-6 relevant keywords should be listed at the end of the abstract page. For the selection of keywords, refer to Medical Subject Headings (MeSH) service of PubMed (https://www.ncbi.nlm.nih.gov/mesh) or that of the US National Library of Medicine (https://meshb.nlm.nih.gov/search).

5.2.4. Main Text
The text for Research Articles should include the following sections: Introduction, Materials and Methods, Results, Discussion, and Conclusions (if any).
• The Introduction should be as concise as possible, without subheadings. A brief background, pertinent references, and previous findings in the field of interest should be presented. Authors are recommended to differentiate the topic-specific background from the general background, to point out issues of debate, and state the specific question(s) to be addressed in the study.
• The Materials and Methods section should be sufficiently detailed. Descriptions of the experimental methods should be concise but sufficient to allow repetition by other qualified investigators. Procedures that have been published previously should not be described in detail, but merely cited with appropriate references. However, new or significant modifications of previously published procedures need full descriptions. The sources of a special chemical(s), equipment(s), or preparation(s) should be given along with the company name and country. All chemicals and reagents should use a generic name, not a brand name.
• For research on humans, the study protocol must be reviewed and approved by the appropriate Institutional Review Board (IRB). The IRB approval number should be provided (e.g. Approval No. 2019013). In addition, informed consent must be obtained from all subjects at the time they are enrolled. For animal experimentation, the procedures used and the care of animals should be approved by the Institutional Animal Care and Use Committee (IACUC) of one of the authors’ institution(s), and the approval number should be provided (e.g. Approval No. 2019011).
• We recommend authors ensure the correct use of the term sex when reporting biological factors, and, unless inappropriate, report the sex of experimental animals or cells, and describe the methods used to determine sex. If the study involved a sex-excluded population (i.e. only one sex), authors should justify the reason for that choice, except in obvious cases (e.g., prostate cancer). Authors should indicate how they determined animal breed and justify the relevance of the breed choice. It is recommended that authors make use of the appropriate reporting guideline services listed above in the Article Category and Reporting Guidelines section.
Subheadings may be used to organize the Results and Discussion.
Sections for Brief Reports are: Introduction, Materials and Methods, Results, and Discussion.
Sections for Case Reports are: Introduction, Case Presentation, and Discussion.
Each section should begin on a new page.

5.2.4.1. Abbreviations
Where a term/definition will be continually referred to, it must be written in full when it first appears in the text, followed by the subsequent abbreviation in brackets. Thereafter, the abbreviation may be used. The use of abbreviations should be kept to a minimum.

5.2.4.2. Ethical Approval
5.2.4.2.1. Research ethics
All manuscripts should be prepared according to the research and publication ethics guidelines recommended by the Council of Science Editors (http://www.councilscienceeditors.org/), the ICMJE (http://www.icmje.org/), the World Association of Medical Editors (WAME, http://www.wame.org/), or the Korean Association of Medical Journal Editors (KAMJE, http://www.kamje.or.kr/intro.php?body=eng_index). All studies involving human subjects or human data must be reviewed and approved by a responsible Institutional Review Board (IRB). Authors should follow the principles embodied in the Declaration of Helsinki (https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects/) for all investigations involving human materials. Animal experiments should be reviewed by an appropriate committee for the care and use of animals (i.e., an Institutional Animal Care and Use Committee; IACUC). Studies with pathogens requiring a high degree of biosafety should pass the review of a relevant committee (i.e., an Institutional Biosafety Committee; IBC). We encourage authors to adhere to animal research reporting standards, for example, the ARRIVE reporting guidelines (https://www.nc3rs.org.uk/arrive-guidelines) for reporting study design and statistical analysis; experimental procedures; experimental animals, and housing and husbandry practices. For studies using client-owned animals, authors should demonstrate a high standard (best practice) of veterinary care that includes obtaining informed client consent. The Editor retains the right to reject manuscripts on the basis of ethical or animal welfare concerns. The approvals obtained for the above should be described in the manuscript’s Methods section. For studies of humans, including case reports, also state whether informed consent was obtained from the study participants. The Editor may request submission of copies of IRB, IACUC, or IBC approval documents and copies of informed consent from human subjects in clinical studies.

5.2.4.2.2. Ethics in research involving animals
A statement explicitly describing the ethical background to this study and any institutional or national ethical committee approvals must be included within the manuscript.

5.2.4.2.3. Animal Studies
A statement indicating that the protocol and procedures employed were ethically reviewed and approved, and the name of the body giving approval must be included in the Methods section of the manuscript. We encourage authors to adhere to animal research reporting standards, for example, the ARRIVE repofrting guidelines (https://www.nc3rs.org.uk/arrive-guidelines) for describing study design, statistical analysis, experimental procedures, experimental animals, and housing and husbandry practices. The authors should also state whether experiments were performed in accordance with relevant institutional and national guidelines and regulations for the care and use of laboratory animals.

5.2.4.3. Informed Consent
For investigations of human subjects, state explicitly in the methods section that informed consent was obtained from all participating adult subjects and from parents or legal guardians for minors or incapacitated adults, together with the manner in which informed consent was obtained (i.e. oral or written).

5.2.4.4. Identification of Patients in Descriptions, Photographs, and Pedigrees
Omitting data or making data less specific to de-identify patients is acceptable but changing any such data is not acceptable.

5.2.4.5. Units
International System of Units (SI) must be used, with the exception of blood pressure values which are to be reported in mmHg. Please use the metric system for the expression of length, area, mass, and volume. Temperatures are to be given in degrees Celsius.

5.2.4.6 Drug Names
Use the Recommended International Non-proprietary Name for medicinal substances, unless the specific trade name of a drug is directly relevant to the discussion.

5.2.4.7. Acupuncture Nomenclature and Traditional Medicine Terminologies
Refer to the Standard Acupuncture Nomenclature (https://apps.who.int/medicinedocs/documents/s7143e/s7143e.pdf) and WHO International Standard Terminologies on Traditional Medicine in the Western Pacific Region (http://www.wpro.who.int/publications/who_istrm_file.pdf) published by the World Health Organization Regional Office for the Western Pacific.

5.2.4.8. Controlled Trials of Acupuncture in Clinical Studies
Use the preferred reporting criteria based on the Guidelines for Clinical Research in Acupuncture (https://apps.who.int/medicinedocs/en/d/Jh2948e/)

5.2.4.9. Statistical Analysis
For manuscripts that report statistics, the JAMS recommends authors to refer the following guidelines on the statistical analysis and its presentation. In case there was consultation with statisticians, authors may provide evidence of statistical consultation (or at least expertise) by either the inclusion of a statistician/epidemiologist among the authors or in the acknowledgments.

5.2.4.9.1. Methods section
• Identify the statistical tests used to analyze the data. • Provide published references for complex or unusual statistical methods (i.e., beyond t-tests, correlation, chi-square, stratified analysis, analysis of variance, regression and survival analysis) • Indicate the prospectively determined p-value that was taken to indicate a significant difference. • Identify any statistics software used. (List software name, version, and company in parentheses in the text, not in the reference list.)

5.2.4.9.2. Results and Discussion sections
• Report actual p-values rather than thresholds: not just whether the p-value was above or below the significant-difference threshold. Example: write "p = 0.18", not "p > 0.05" or "p = NS."
• p-value should be expressed to 2 significant digits for p ≥ 0.01 because expressing p to more than 3 digits does not add useful information. (e.g. p = 0.054; not p = 0.05372). If p < 0.001, it should be expressed as p < 0.001, rather than p < 0.0001 or p = 0.00001 for example. In certain types of studies, it may be important to express p-values to more significant digits. If p > 0.99, p = 0.999 for example, it should be expressed as p > 0.99.
• Present only meaningful digits. A practical rule is to round values so that the change caused by rounding is less than one-tenth of the standard error. Such rounding increases the variance of the reported value by less than 1% so that less than 1% of the relevant information contained in the data is sacrificed. In most cases, 2 or 3 significant digits (not decimal places) are sufficient.
• If the number of observations is small, present all of the data (e.g., scatterplot in which results for each animal are depicted). Avoid tables containing individual animal data.
• Provide appropriate descriptive statistics.
1) For numerical data, provide the number of observations, a measure of central tendency (such as mean or median), and a measure of variability (standard deviation [SD], range or inter-percentile ranges [deciles, quartiles]), as appropriate for the data. Present the SD, rather than the standard error of the mean (SEM) to show variability among individuals or individual responses. The SEM or 95% confidence intervals (CI) are appropriate statistics for reporting the reliability of estimated parameters, including mean effects such as odds ratios.
2) For categorical data, provide the numerator and denominator for each proportion (percentage) in each group and category. Cut-points used to create categorical variables from continuous data must be explained and justified. The calculation of proportions to summarize small samples (< 20) is uninformative and should be avoided.
• Manuscripts should concentrate on differences that are biologically important rather than merely statistically significant. Very small unimportant differences can be statistically significant if the sample size is large enough. A "nonsignificant" relationship or difference (e.g. xx ± yy and aa ± bb, respectively, in groups 1 and 2, p = 0.056) should not be interpreted to suggest the absence of a relationship or difference simply because of P > 0.05. Before declaring that “There was no difference …”, you should state what a biologically important difference would be, and state the power to find that difference. Otherwise, use phrases such as “We did not detect a difference …” and then discuss the reasons for the lack of a difference, or mention the limitations of your study in the discussion if this is important to the study.
• In analyzing repeated observations on an individual, use appropriate methods of statistical analysis that account for the correlation among observations.
• Randomized controlled trials (RCTs) and other studies of the effect of intervention often involve small sample sizes and might be underpowered, resulting in type II (false negative) error. Manuscripts describing RCTs or other studies examining the effect of an intervention (e.g. administration of a drug) must specify the primary outcome of interest, describe how sample size was determined (including all elements used in calculations), and report the CI for observed treatment effects.

5.2.4.10. Acknowledgments
General acknowledgments for consultations, statistical analysis, etc., should be listed at the end of the text, including the names of the individuals involved. All financial and material support for the research and the work should be clearly and completely identified. Ensure that any conflicts of interest are explicitly declared

5.2.5. References
• References should be assembled on a separate sheet and should be limited to those cited in the text.
• Each reference citation within the main body of the text should be an Arabic numeral enclosed in square brackets on the same line as the text, not a superscript.
• References must be numbered consecutively in the order of appearance in the text, and listed in numerical order in the reference list: do not alphabetize.
• References cited in tables or figure legends should be included in sequence at the point where the table or figure is first mentioned in the main text.
• Abstracts should not be cited unless the abstract is the only available reference to an important concept.
• Do not cite uncompleted work or work that has not yet been accepted for publication as references.
• References should include the complete title of the article and the last names and initials of all the authors up to 6. If there are 7 or more authors, include the last names and initials of the first 6 authors only, followed by "et al".
• Abbreviations for journal titles should conform to those used in MEDLINE.
• If citing a website, please provide the author information, article title, website address and the date you accessed the information.
• Reference to an article that is in press must state the journal name and, if possible, the year and volume.

Authors are responsible for the accuracy and completeness of their references and for correct text citation.

Examples are given below.

Journal articles:
1. Streitberger K, Steppan J, Maier C, Hill H, Backs J, Plaschke K. Effects of verum acupuncture compared to placebo acupuncture on quantitative EEG and heart rate variability in healthy volunteers. J Altern Complement Med 2008;14:505-13.
2. Yeh GY, Ryan MA, Phillips RS, Audette JF. Doctor training and practice of acupuncture: results of a survey. J Eval Clin Pract 2008;14:439-45.
3. Chien CM, Cheng JL, Chang WT, Tien MH, Tsao CM, Chang YH, et al. Polysaccharides of Ganoderma lucidum alter cell immunophenotypic expression and enhance CD56+ NK-cell cytotoxicity in cord blood. Bioorg Med Chem 2004;12:5603–9.

Book:
Robinson AJ, Snyder-Mackler L. Clinical Electrophysiology: Electrotherapy and Electrophysiologic Testing, 3rd ed. Philadelphia: Lippincott Williams & Wilkins, 2007.

Book chapter:
Baldry P. Acupuncture treatment of fibromyalgia and myofascial pain. In: Chaitow L, ed. Fibromyalgia Syndrome: A Practitioner’s Guide to Treatment, 2nd ed. Edinburgh: Churchill Livingstone, 2003:113–27.

Conference proceedings:
Pacak K, Aguilera G, Sabban E, Kvetnansky R, eds. Stress: Current Neuroendocrine and Genetic Approaches. 8th Symposium on Catecholamines and Other Neurotransmitters in Stress, June 28- July 3, 2003, Smolenice Castle, Slovakia. New York: New York Academy of Sciences, 2004.

Website:
National Cancer Institute. Acupuncture (PDQ). Available at: https://www.cancer.gov/about-cancer/treatment/cam/hp/acupuncture-pdq [Date accessed: July 21, 2008]

5.2.6. Tables
Tables should supplement, not duplicate, the text. They should be numbered consecutively using Arabic numerals in the order of their citation in the text. Tables should be typed double-spaced on separate pages in as simple a form as possible, with a short descriptive title typed directly above and with essential footnotes below.
Information requiring explanatory footnotes should be denoted using these symbols (in order of appearance): *, †, ‡, §, ?, ¶, #, **, ††, ‡‡. Abbreviations used in the table must be defined in the footnotes. If you include data from another source, whether published or unpublished, you must acknowledge the original source.

5.2.7. Figures
The number of figures should be restricted to the minimum necessary to support the textual material.
Figures should be labeled in Arabic numerals in the order of their citation in the text. All symbols and abbreviations should be defined in the legend. Figure legends should indicate the anatomic area and/or pathologic condition shown. Patient identification should be obscured. All lettering should be done professionally and should be in proportion to the drawing, graph or photograph. For photomicrographs, include the type of specimen, original magnification, and stain.
Each figure should be submitted separately in high-resolution EPS, TIFF, JPEG, or PPT format. Please ensure that files are supplied at the correct resolution of a minimum of 300 dpi. The files are to be named according to the figure number and format, e.g. Fig1.tif.

5.2.8. Video data
Elsevier accepts video material and animation sequences to support and enhance your scientific research. Authors who have video or animation files that they wish to submit with their article are strongly encouraged to include links to these within the body of the article. This can be done in the same way as a figure or table by referring to the video or animation content and noting in the body text where it should be placed. All submitted files should be properly labeled so that they directly relate to the video file's content. In order to ensure that your video or animation material is directly usable, please provide the files in one of our recommended file formats with a preferred maximum size of 150 MB. Video and animation files supplied will be published online in the electronic version of your article in Elsevier Web products, including ScienceDirect: http://www.sciencedirect.com. Please supply 'stills' with your files: you can choose any frame from the video or animation or make a separate image. These will be used instead of standard icons and will personalize the link to your video data. For more detailed instructions please visit our video instruction pages at https://www.elsevier.com/artworkinstructions. Note: since video and animation cannot be embedded in the print version of the journal, please provide text for both the electronic and the print version for the portions of the article that refer to this content.

5.2.9. Supplementary material
Supplementary material can support and enhance your scientific research. Supplementary files offer the author additional possibilities to publish supporting applications, high-resolution images, background datasets, sound clips and more. Please note that such items are published online exactly as they are submitted; there is no typesetting involved (supplementary data supplied as an Excel file or as a PowerPoint slide will appear as such online). Please submit the material together with the article and supply a concise and descriptive caption for each file. If you wish to make any changes to supplementary data during any stage of the process, then please make sure to provide an updated file, and do not annotate any corrections on a previous version. Please also make sure to switch off the 'Track Changes' option in any Microsoft Office files as these will appear in the published supplementary file(s). For more detailed instructions please visit our artwork instruction pages at https://www.elsevier.com/artworkinstructions.

5.3. Editorial and Peer Review Process As a general rule, the receipt of a manuscript will be acknowledged by e-mail within 2 weeks of submission, and authors will be provided with a manuscript number for future correspondence. If such an acknowledgment is not received in a reasonable period of time, the author should contact the Editorial Office.
Manuscripts are reviewed by the Editorial Office to ensure that the submission contains all parts. The Editorial Office will not accept a submission if the author has not supplied all parts of the manuscript as outlined in this document. Manuscripts are then forwarded to the Editor-in-Chief, who makes an initial assessment of the manuscript. If the manuscript does not appear to be of sufficient merit or is not appropriate for the journal, then the manuscript will be rejected. Manuscripts that appear meritorious and appropriate for the journal are reviewed by at least two Editorial Board members or consultants assigned by the Editor-in-Chief. Authors should, at the time of manuscript submission, also submit a list of up to five suggested reviewers whom they wish to review their manuscript. Authors will usually be notified within 10 weeks by e-mail of whether the submitted article is accepted for publication, rejected, or subject to revision before acceptance. However, do note that delays are sometimes unavoidable.
The publisher of the Journal of Acupuncture and Meridian Studies, Elsevier, is a member of the CrossCheck plagiarism detection initiative. In cases of suspected plagiarism CrossCheck is available to the editors of Journal of Acupuncture and Meridian Studies to detect instances of overlapping and similar text in submitted manuscripts. CrossCheck is a multi-publisher initiative allowing screening of published and submitted content for originality.

Peer review
This journal operates a single-blind review process. All contributions will be initially assessed by the editor for suitability for the journal. Papers deemed suitable are then sent to a minimum of two independent expert reviewers to assess the scientific quality of the paper. The Editor is responsible for the final decision regarding acceptance or rejection of articles. The Editor's decision is final. For more information on the types of peer review, please visit: https://www.elsevier.com/reviewers/peer-review.

6. After Acceptance

6.1. Use of the Digital Object Identifier The Digital Object Identifier (DOI) may be used to cite and link to electronic documents. The DOI consists of a unique alpha-numeric character string that is assigned to a document by the publisher upon the initial electronic publication. The assigned DOI never changes. Therefore, it is an ideal medium for citing a document, particularly 'Articles in press' because they have not yet received their full bibliographic information. Example of a correctly given DOI (in URL format; here an article in the journal Physics Letters B): http://dx.doi.org/10.1016/j.physletb.2010.09.059 When you use a DOI to create links to documents on the web, the DOIs are guaranteed never to change.

6.2. Proofs One set of page proofs (as PDF files) will be sent by e-mail to the corresponding author (if we do not have an e-mail address then paper proofs will be sent by post) or, a link will be provided in the e-mail so that authors can download the files themselves. Elsevier now provides authors with PDF proofs which can be annotated; for this you will need to download Adobe Reader version 9 (or higher) available free from http://get.adobe.com/reader. Instructions on how to annotate PDF files will accompany the proofs (also given online). The exact system requirements are given at the Adobe site: http://www.adobe.com/products/reader/tech-specs.html. If you do not wish to use the PDF annotations function, you may list the corrections (including replies to the Query Form) and return them to Elsevier in an e-mail. Please list your corrections quoting line number. If, for any reason, this is not possible, then mark the corrections and any other comments (including replies to the Query Form) on a printout of your proof and scan the pages and return via e-mail. Please use this proof only for checking the typesetting, editing, completeness and correctness of the text, tables and figures. Significant changes to the article as accepted for publication will only be considered at this stage with permission from the Editor. We will do everything possible to get your article published quickly and accurately. It is important to ensure that all corrections are sent back to us in one communication: please check carefully before replying, as inclusion of any subsequent corrections cannot be guaranteed. Proofreading is solely your responsibility.

6.3. Author fees Neither page charge, article processing charge (also known as a publication fee) for accepted articles nor submission fee will be applied. It is the platinum open access journal.

Elsevier supports responsible sharing
Find out how you can share your research published in Elsevier journals.
Use of word processing software
It is important that the file be saved in the native format of the word processor used. The text should be in single-column format. Keep the layout of the text as simple as possible. Most formatting codes will be removed and replaced on processing the article. In particular, do not use the word processor’s options to justify text or to hyphenate words. However, do use boldface, italics, subscripts, superscripts, etc. When preparing tables, if you are using a table grid, use only one grid for each individual table and not a grid for each row. If no grid is used, use tabs, not spaces, to align columns. The electronic text should be prepared in a way very similar to that of conventional manuscripts (see also the Guide to Publishing with Elsevier). Note that source files of figures, tables, and text graphics will be required whether or not you embed your figures in the text. See also the section on Electronic artwork.
To avoid unnecessary errors you are strongly advised to use the ‘spell-check’ and ‘grammar-check’ functions of your word processor.

Antibody data
Antibody Data is the reference application linking to information about the antibodies mentioned in the article, based on the NIF Antibody Registry. Authors are encouraged to include relevant antibody identifiers in their articles (e.g. Antibody Registry: AB_878537 or RRID: AB_878537) if appropriate. More information.

Author Inquiries
You are welcome to contact Customer Support via http://support.elsevier.com.

Journal Info

JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY
June, 2020
Vol.23 No.2

pISSN 2093-6966
eISSN 2234-6856
Quarterly

Archives >

Editorial Office

Fax
Fax +82-2-2658-9136

Most Read / Downloaded

  • Systematic Review2020-06-30

    Bee Venom Acupuncture for Shoulder Pain: A Systematic Review and Meta-analysis of Randomized Controlled Trials

    Lei Shen1,†, Jong Ha Lee2,†, Jong Cheon Joo1, Soo Jung Park3,*, and Yung Sun Song4,*
    J Pharmacopuncture 2020; 23(2): 44-53 https://doi.org/10.3831/KPI.2020.23.008

    Abstract : ObjectivesOur review aimed to summarize and evaluate evidence on the effectiveness of bee venom acupuncture (BVA) in the treatment of shoulder pain.MethodsRandomized controlled trials (RCTs) evaluating the effectiveness of BVA on shoulder pain were searched up to October 2019 in 11 electronic databases (Medline, Embase, CENTRAL, CiNii, CNKI, VIP, Wanfang, Kmbase, NDSL, RISS, OASIS). The methodological quality of the included RCTs were evaluated using Cochrane Risk of Bias tool and a meta-analysis was performed.ResultsSeven studies were included in the review, and four studies were included in the meta-analysis. Comparing BVA plus conventional therapy (CT) with saline injection plus CT, it showed an effect in favor of BVA plus CT in visual analog scale (VAS) and pain rating scale (PRS) (p = 0.02, p = 0.009, respectively). Comparing BVA plus physiotherapy (PT) with saline injection plus PT, it showed that there was no significant difference in VAS and verbal rating scale (VRS) between the two groups.ConclusionThis systematic review and meta-analysis suggest that BVA could be beneficial as an adjuvant treatment for shoulder pain.

    Abstract
  • Review Article2020-03-31

    Nicotine Addiction: Neurobiology and Mechanism

    Raj Kumar Tiwari1, Vikas Sharma1, Ravindra Kumar Pandey2, and Shiv Shankar Shukla2,*
    J Pharmacopuncture 2020; 23(1): 1-7 https://doi.org/10.3831/KPI.2020.23.001

    Abstract : Nicotine, primary component of tobaco produces craving and withdrawal effect both in humans and animals. Nicotine shows a close resemblance to other addictive drugs in molecular, neuroanatomical and pharmacological, particularly the drugs which enhances the cognitive functions. Nicotine mainly shows its action through specific nicotinic acetylcholine receptors located in brain. It stimulates presynaptic acetylcholine receptors thereby enhancing Ach release and metabolism. Dopaminergic system is also stimulated by it, thus increasing the concentration of dopamine in nuclear accumbens. This property of nicotine according to various researchers is responsible for reinforcing behavioral change and dependence of nicotine. Various researchers have also depicted that some non dopaminergic systems are also involved for rewarding effect of nicotinic withdrawal.Neurological systems such as GABAergic, serotonergic, noradrenergic, and brain stem cholinergic may also be involved to mediate the actions of nicotine. Further, the neurobiological pathway to nicotine dependence might perhaps be appropriate to the attachment of nicotine to nicotinic acetylcholine receptors, peruse by stimulation of dopaminergic system and activation of general pharmacological changes that might be responsible for nicotine addiction. It is also suggested that MAO A and B both are restrained by nicotine. This enzyme helps in degradation dopamine, which is mainly responsible for nicotinic actions and dependence. Various questions remain uninsurable to nicotine mechanism and require more research. Also, various genetic methods united with modern instrumental analysis might result for more authentic information for nicotine addiction.

    Abstract
  • Review Article2020-06-30

    Current and Future molecular mechanism in Inflammation and Arthritis

    Vikash Sharma1, Raj Kumar Tiwari1, Shiv Shankar Shukla1, and Ravindra Kumar Pandey1,*
    J Pharmacopuncture 2020; 23(2): 54-61 https://doi.org/10.3831/KPI.2020.23.009

    Abstract : Inflammation is an immune response of the human body but excessive inflammation is taken as a major factor in the development of many diseases including autoimmune disorders, cancer and nerve disorders etc. In this regards the need is to suppress the inflammatory response. Suppression of extra or imperfect inflammatory response is not a big deal provided there is an exact knowledge of particular target in the body. Recent advancements in Pharmacological aspect made the therapy with improved outcomes in number of patients. Anticytokine therapy might be one of the important and novel approaches for inflammation and Arthritis. This can be achieved only when we go through the pathophysiology of expression and identification of mediators. Let’s take an example of cytokine like interleukins (IL), chemokines, interferons (INF), tumor necrosis factors (TNF-α), growth factors, and colony stimulating factors) release pathway which is a major signalling protein in inflammatory response. In the present study we have reviewed the recent pharmacological therapeutic advancement, inflammatory mediators, receptors, and major signalling pathways. Such information will not only provide the idea about the mechanism of action of Pharmaceuticals and molecular targets but also it provides a new aspect for drug designing and new corrective approaches in existing clinical medicines. This study will be a source of good information for the researchers working in the area of drug designing and molecular Pharmacology especially in anti-inflammatory and anti arthritic medicines for target based therapy.

    Abstract
All Newest Articles
  • Original Article2019-10-01

    Evaluation of the Single-Dose Toxicity of TA Pharmacopuncture in Rats

    Ji Hye Hwang1,*, Hyo Won Jung2, and Chul Jung3,*
    J Pharmacopuncture 2019; 22(3): 171-175 https://doi.org/10.3831/KPI.2019.22.023

    Abstract : ObjectivesTA is a polyherbal extract comprising seven herbs, typically used for the pharmacopuncture treatment of patients with traffic accident-related injuries and musculoskeletal diseases. This animal study was conducted to evaluate the safety of the TA extract, using a single-dose toxicity test.MethodsThe dose range and sampling time were first established. Six-week-old Sprague–Dawley rats were administered 1.0 mL of TA or normal saline (control), intramuscularly, for the single-dose toxicity test. The general condition, mortality, and histology of all rats were observed for 2 weeks.ResultsNo abnormal symptoms or deaths were observed in any group. The body weights of the rats in the TA and control groups were similar. No significant differences in histopathology were observed between the groups.ConclusionOur study indicates that 1.0 mL of TA extract may be safely administered for pharmacopuncture for treatment of patients in traditional medicine clinics.

    Abstract
  • Opinions2020-06-30
  • Review Article2020-06-30

    Current and Future molecular mechanism in Inflammation and Arthritis

    Vikash Sharma1, Raj Kumar Tiwari1, Shiv Shankar Shukla1, and Ravindra Kumar Pandey1,*
    J Pharmacopuncture 2020; 23(2): 54-61 https://doi.org/10.3831/KPI.2020.23.009

    Abstract : Inflammation is an immune response of the human body but excessive inflammation is taken as a major factor in the development of many diseases including autoimmune disorders, cancer and nerve disorders etc. In this regards the need is to suppress the inflammatory response. Suppression of extra or imperfect inflammatory response is not a big deal provided there is an exact knowledge of particular target in the body. Recent advancements in Pharmacological aspect made the therapy with improved outcomes in number of patients. Anticytokine therapy might be one of the important and novel approaches for inflammation and Arthritis. This can be achieved only when we go through the pathophysiology of expression and identification of mediators. Let’s take an example of cytokine like interleukins (IL), chemokines, interferons (INF), tumor necrosis factors (TNF-α), growth factors, and colony stimulating factors) release pathway which is a major signalling protein in inflammatory response. In the present study we have reviewed the recent pharmacological therapeutic advancement, inflammatory mediators, receptors, and major signalling pathways. Such information will not only provide the idea about the mechanism of action of Pharmaceuticals and molecular targets but also it provides a new aspect for drug designing and new corrective approaches in existing clinical medicines. This study will be a source of good information for the researchers working in the area of drug designing and molecular Pharmacology especially in anti-inflammatory and anti arthritic medicines for target based therapy.

    Abstract
All Newest Articles

Scimago Journal & Country Rank

SCImago Journal & Country Rank